CEOInterviews.AI
Start App
Get an email when Mark Cuban gives a new interview
One email per new interview. Unsubscribe in one click.
Mark Cuban
Co-founder; minority owner, Dallas Mavericks, Cost Plus Drugs

Mark Cuban Is Battling Big Pharma—And Winning | The Big Interview | WIRED

📅 Dec 04, 2024 WIRED 29 MIN 182738 VIEWS 78 SEGMENTS · 2 SPEAKERS
His time on Shark Tank may be over, but this serial investor is just getting started. The Cost Plus Drugs founder shares how he’s demolishing–and rebuilding–the prescription drug industry with WIRED’s Lauren Goode. Still haven’t subscribed to WIRED on YouTube? ►► http://wrd.cm/15fP7B7 Listen to the Get WIRED podcast ►► https://link.chtbl.com/wired-ytc-desc Want more WIRED? Get the magazine ►► https://subscribe.wired.com/subscribe... Follow WIRED: Instagram ►►  / wired   Twitter ►►  / wired   Facebook ►►  / wired   Tik Tok ►►  / wired   Get more incredible stories on science and...

Questions asked in this interview

12
  1. 1:01So I asked a friend here, actually, Sean, earlier today, I said, 'What should I kick Mark Cuban with?
  2. 1:21Why did you get into pharma?
  3. 3:36What are some of the common drugs people might recognize that you're manufacturing and selling?
  4. 9:57How is this potentially going to affect Cost Plus?
  5. 10:43Have you talked to Donald Trump about this?
  6. 11:47When you look back at this election season, is there anything that you think you would have done differently or taken a different approach in terms of how you were communicating?
  7. 12:29What's interesting is because my response to you was, 'Isn't that sort of a fringe issue?' And you said, 'No.' But how many people here own crypto?
  8. 16:15One thing I'll say about AI, and then we should move on from it, is that when we spoke for the Big Interview, you asked me, what would you trust more in an environment if you weren't able to see, a self-driving car or a seeing-eye dog?
  9. 20:03In a sense, how does that fix anything?
  10. 23:26How do we distinguish reality on social media, what's really happening?
  11. 25:43More couch stuff, for real, right?
  12. 26:05And you really do think that would have altered the outcome of the election?
Interviewer 0:00 ↗
Thank you so much for being here. I don't think our next guest needs much of an introduction, but I've been given one, so I'm excited to welcome entrepreneur, co-founder of Cost Plus Drugs, Mark Cuban, to the Big Interview stage. From selling garbage bags door to door at age 12 to founding a lot of groundbreaking tech companies, Mark has always been ahead of the curve. It's really no surprise that with his latest venture, Cost Plus Drugs, he's also ahead of the curve, working to demolish and rebuild the prescription drug industry. And that's what we're going to talk about today. Everyone, please welcome Mark Cuban.
Mark Cuban 0:46 ↗
Thanks.
Interviewer 0:47 ↗
Mark, thank you so much for being here. I liked how you changed up to 'demolish', you know.
Mark Cuban 0:54 ↗
Oh, it's a family-friendly event.
Interviewer 0:57 ↗
Oh, that I should leave right now.
Mark Cuban 0:59 ↗
This is just like Shark Tank.
Interviewer 1:01 ↗
So I asked a friend here, actually, Sean, earlier today, I said, 'What should I kick Mark Cuban with? What should I say?' And he said, 'Why don't you give him a belated congratulations for Klay Thompson?'
Mark Cuban 1:13 ↗
Oh, there you go. Klay is killing it. We thank everybody here for... yeah, you're lucky that you're welcome in the Bay after that one. Actually, I look over my shoulder.
Interviewer 1:21 ↗
Yeah. All right, so let's talk about Cost Plus. When our issue came out, in which you're prominently featured, one thing I heard from people was, 'I didn't know Mark Cuban was in the pharmaceutical business.' You've been doing this for a while, though. Why did you get into pharma?
Mark Cuban 1:38 ↗
Does anybody here like their health care? Does anybody here think the health care industry works well? That's why. I mean, I literally got a cold email from a Dr. Alex Oshmanski who wanted to start up a compounding pharmacy, which actually makes drugs that are, in this case, on short supply, that are on a shortage list. And I'm like, 'You're thinking too small.' And that was right around the time Martin Shkreli was going to jail, so he was in the news, and I was like, 'How can this one guy take control of this drug and jack up the price that dramatically?' And so I'm like, 'Let me just take a look.' And when you look at the pharmaceutical industry back then, it was very obvious that it was opaque. There was no transparency at all. I mean, think about it: if you get a prescription from your doctor, what's the first thing they ask you? Not 'Can you afford it?' It's 'What pharmacy do you use?' And that's it. And then you've got to deal with the fear of 'Can you afford it?' or 'What's the impact? What's the copay? What's the deductible?' All those things. So we said, 'Okay, let's start a company called CostPlusDrugs.com and let's make it transparent.' And it seems so simple, but the impact has been so dramatic. So if you go to CostPlusDrugs.com and you put in the name of the medication, and we've grown from 111 to 2,500, and we have more to go, if we carry it, the medication pops up and you'll see our actual cost. So we'll show you what we pay for it. We mark it up 15% if you want it delivered, and then there's a $5 pharmacist fee that's included because you have to have a pharmacist review it, then $5 to ship it to you. Or you can now, we have an affiliate network where you can pick it up at a local pharmacy just by showing our price, our cost, and only marking up 15%. We were able to take down the price of drugs like a chemotherapy drug, MS drugs, from like $2,000-plus a month to $21 a month, $35 a month. So the impact has been insane.
Interviewer 3:36 ↗
What are some of the common drugs people might recognize that you're manufacturing and selling?
Mark Cuban 3:43 ↗
I mean, selling, you know, imatinib is probably the most dramatic example. I'm not the pharmacist to remember all the funky names, but people with MS, as an example, we're able to take... There's a drug called droxidopa that... I'll give you a scenario. A friend of mine was in this horrific car accident and he needed to take this drug and lost his insurance, emailed me and said, 'Okay, they're telling me it's going to be $10,000 every three months.' I'm like, 'Okay, Landon, I'll check into it.' Turns out we carried it, and when we carried it back then, it was $64 a month, from $10,000 to 64 times 3, and now it's in the $20s because as our volumes go up, because we do everything on a straight markup, our costs go down. And literally, we have lowered the price of a medication every single weekday for the past almost 18 months. And so if you think about it, but the most dramatic thing we did was unintentional. We published our entire price list. And so there's places, if you really looked hard, you can go and find a price for a medication that you might need, but there's no place where the company published their entire price list. And we did that for all 2,500 drugs. And what's happened now is that researchers are able to use that price list to compare to what the government is paying for things, to compare to what states are paying. And if you have a company that self-insures, to start the process of allowing you to compare what the company pays for the medications that their employees and the people that they cover, the population they cover, what they pay. And that has just been a game changer. I mean, we've had researchers from Vanderbilt, Harvard, all these different places say, you know, if Medicare bought these nine drugs from Cost Plus Drugs, just nine drugs would save $3.6 billion a year. If they bought these 11 drugs, that, you know, they might, it's $6.3 billion a year. I mean, it's insane. And literally, you know, for so many folks out here in the Valley, probably the easiest way to raise money and put cash in your own pocket is to change your health care plan, and in particular your pharmacy benefit manager, because the crux of this problem and the opacity of the industry, there are three pharmacy benefit managers that control, give or take, 80% of the market.
Interviewer 6:08 ↗
So these are basically the middlemen.
Mark Cuban 6:11 ↗
The middlemen, yeah. And literally, they don't want you to know what you pay. If you work with a self-insured company and they're working with one of the big three, let's just say the biggest PBMs, you're getting ripped off, guaranteed. The quickest way to raise money if you have over 100 employees and self-insure is to change your health care program, and in particular, pharmacy benefit manager. That's immediate cash in the bank. And, you know, companies don't really realize that, and that's why it's been so successful. Because the next question always is, how did this happen? And the reality is there's 155 million people covered by self-insured employers, and it's not the core competency of a CEO to understand all their health care benefits, right? You just don't, right? I mean, like, you could ask a couple of them here on stage today if you want. Happy to. Yeah, Brian Chesky, let's talk to him. You know, Jay Wong, I'm sure he wants to talk about health plans. You know, just say, would you... No, seriously, ask them, why are you dealing with one of the big pharmacy benefit managers? And ask them, is that... because here's what's happening that's crazy, that they're going to be... Here's why they're starting to understand. There's a law called ERISA that requires the employer now to take on the fiduciary responsibility for the cost and care of all the lives they cover as employers. And J&J and Wells Fargo just got sued, and they're going to lose, which effectively means that every single major self-insured employer is going to get sued in a class action suit. And so if any of you fall into that trap, get ready, they're coming. But the bigger point, again, is now there's transparency for medications, and you can cut the cost whether you're a little company or a big company. And if you have a high deductible or you're uninsured, always check the pricing because otherwise you're going to get ripped off.
Interviewer 8:07 ↗
So you've made it pretty clear you're not doing this for altruistic reasons. You're running a business. You want this to be a profitable business. I think people hear about what you're doing and they think, oh, it's altruistic, like it's because you're doing something good.
Mark Cuban 8:20 ↗
Well, I could make more money, right? But what you said, seriously, but we're a public benefit corporation. But how much money do I need? You know, I'm not trying to land on Mars, you know. It's just... and not to take anything away from him for trying, more power to them. But the reality is, I mean, at this point in my life, it's just like, more money... f*** up the health care industry.
Interviewer 8:55 ↗
That was the word I left out of the intro, guys. F*** the health care industry. But how did you... But I guess what I'm getting at is, like, how did you decide on that being the industry you wanted to go after?
Mark Cuban 9:07 ↗
Because it was so obvious that it would be easy to change, that it was insane. What had happened in the past is I dug in more, and we've been in business now, we started shipping, you know, two and a half years ago, and, you know, now we have millions of people whose lives we've changed. But you start to realize that what the incumbents would do was they'd go in and just buy companies. So anybody that was a threat, they'd just buy them. And one after another, we'd go into situations where we're talking to employers or whatever, and they're saying, 'Yeah, we were going to do business with this company, and they were trying to cut the cost, but then so-and-so bought them.' And like I said, that's just not in the cards for us.
Interviewer 9:46 ↗
Let's talk about tariffs.
Mark Cuban 9:49 ↗
Ugh, tariffs. Tariffs.
Interviewer 9:52 ↗
Okay, so President-elect Donald Trump is...
Mark Cuban 9:54 ↗
I know who he is, yeah. Heard of him.
Interviewer 9:57 ↗
Okay, so he said that he's planning to impose tariffs on Canada, Mexico, China, day one. We don't know exactly how that's going to shake out yet, but we do know that this could affect the drug industry. I mean, he's referring often to the illegal drug industry, but also this could affect the pharmaceutical business. How is this potentially going to affect Cost Plus?
Mark Cuban 10:15 ↗
I mean, if it's just China, it won't impact us at all.
Interviewer 10:17 ↗
Why is that?
Mark Cuban 10:18 ↗
Because we had... because I checked, we had 16 drugs that we bought that were shipped from China, and we're changing that to a different manufacturer. So the Chinese tariffs won't impact us at all. Okay, and now we do get drugs from India, so we'll see what happens there. But if there are tariffs, we only have 15%, and so, you know, we'd have to pass them through.
Interviewer 10:39 ↗
Pass them through, meaning the cost goes to the consumer.
Mark Cuban 10:41 ↗
The cost would go up because our cost would go up.
Interviewer 10:43 ↗
Okay. Have you talked to Donald Trump about this?
Mark Cuban 10:48 ↗
Sure. I was like, 'Yo, what's up, bro?' Yeah, no, I have not.
Interviewer 10:55 ↗
You have not. If the conversation were to occur, if you were invited to have it, what's your priority? What's the first thing you would say?
Mark Cuban 11:01 ↗
I would say, 'Don't f*** it up. It's working.' You know, I mean, I don't... look, there's no point in trying to guess what he's going to do and speculate because we don't know. I don't think he knows yet. I think he's trying to, you know, he plays it by ear, and he'll go where he goes, and we'll react accordingly. But I think, you know, he's obviously very cognizant of PR and the idea that medication from the cheapest provider going up in price means more people aren't able to afford it. I really don't think he's going in that direction. You know, I really think he'd make an exception.
Interviewer 11:33 ↗
You were clearly a vocal supporter of Kamala Harris for president. When you look back at...
Mark Cuban 11:41 ↗
You see how good a job I did.
Interviewer 11:47 ↗
When you look back at this election season, is there anything that you think you would have done differently or taken a different approach in terms of how you were communicating?
Mark Cuban 11:57 ↗
Not really. I mean, I'm not the candidate. I did the best I could to try to convey, you know, what she was doing for business people, small business, you know. And I think, you know, the message was good, but, you know, they weren't voting or not voting for me.
Interviewer 12:13 ↗
Yeah. One of the things that we talked about when we did the Big Interview in the magazine was crypto. And, you know, you feel pretty strongly you're in favor of crypto, and you're in favor of it not being villainized, and you felt as though that's what Gary Gensler and the SEC had been doing.
Mark Cuban 12:27 ↗
Yeah, and I think it really hurt her.

39 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Cuban, M. (2024, December 4). Mark Cuban Is Battling Big Pharma—And Winning | The Big Interview | WIRED [Interview transcript]. WIRED. CEOInterviews.AI. https://ceointerviews.ai/interview/3054512/

MLA

Mark Cuban. "Mark Cuban Is Battling Big Pharma—And Winning | The Big Interview | WIRED." WIRED, 4 Dec. 2024. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3054512/.

BibTeX
@misc{cuban2024_3054512,
  author       = {Mark Cuban},
  title        = {Mark Cuban Is Battling Big Pharma—And Winning | The Big Interview | WIRED},
  howpublished = {Interview transcript, WIRED. CEOInterviews.AI},
  year         = {2024},
  month        = {dec},
  url          = {https://ceointerviews.ai/interview/3054512/},
  note         = {Speaker-attributed transcript with timestamps}
}